- Home
- NCRA vs CLRB Comparison
NCRA vs CLRB Comparison
Compare NCRA & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- CLRB
- Stock Information
- Founded
- NCRA 2002
- CLRB 2002
- Country
- NCRA Taiwan
- CLRB United States
- Employees
- NCRA N/A
- CLRB N/A
- Industry
- NCRA Farming/Seeds/Milling
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- CLRB Health Care
- Exchange
- NCRA Nasdaq
- CLRB Nasdaq
- Market Cap
- NCRA 13.9M
- CLRB 12.5M
- IPO Year
- NCRA N/A
- CLRB N/A
- Fundamental
- Price
- NCRA $1.00
- CLRB $0.24
- Analyst Decision
- NCRA
- CLRB Hold
- Analyst Count
- NCRA 0
- CLRB 2
- Target Price
- NCRA N/A
- CLRB N/A
- AVG Volume (30 Days)
- NCRA 83.1K
- CLRB 729.7K
- Earning Date
- NCRA 05-06-2025
- CLRB 05-13-2025
- Dividend Yield
- NCRA N/A
- CLRB N/A
- EPS Growth
- NCRA N/A
- CLRB N/A
- EPS
- NCRA N/A
- CLRB N/A
- Revenue
- NCRA $17,013,132.00
- CLRB N/A
- Revenue This Year
- NCRA N/A
- CLRB N/A
- Revenue Next Year
- NCRA N/A
- CLRB N/A
- P/E Ratio
- NCRA N/A
- CLRB N/A
- Revenue Growth
- NCRA N/A
- CLRB N/A
- 52 Week Low
- NCRA $0.70
- CLRB $0.22
- 52 Week High
- NCRA $2.09
- CLRB $3.49
- Technical
- Relative Strength Index (RSI)
- NCRA 53.09
- CLRB 38.54
- Support Level
- NCRA $0.87
- CLRB $0.24
- Resistance Level
- NCRA $1.03
- CLRB $0.27
- Average True Range (ATR)
- NCRA 0.12
- CLRB 0.02
- MACD
- NCRA 0.00
- CLRB -0.00
- Stochastic Oscillator
- NCRA 52.38
- CLRB 11.89
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.